Molecule Details
| InChIKey | RHLJLALHBZGAFM-UHFFFAOYSA-N |
|---|---|
| Compound Name | Bunazosin |
| Canonical SMILES | CCCC(=O)N1CCCN(c2nc(N)c3cc(OC)c(OC)cc3n2)CC1 |
| Clinical Status | Data-mined Candidate |
| Targets (Human+Pathogen) | 3 |
| Pfam Stratification | Homologous |
| Avg pChEMBL | 8.91 |
| Source | ChEMBL |
2D Structure
Activity Profile
DrugBank Annotations
| DrugBank ID | DB12230 |
|---|---|
| Drug Name | Bunazosin |
| CAS Number | 80755-51-7 |
| Groups | investigational |
| ATC Codes | nan |
| Description | Bunazosin has been used in trials studying the treatment of High Blood Pressure. |
Categories: Adrenergic Agents Adrenergic Antagonists Adrenergic alpha-1 Receptor Antagonists Adrenergic alpha-Antagonists Heterocyclic Compounds, Fused-Ring Neurotransmitter Agents Peripheral alpha-1 blockers
Cross-references: BindingDB: 50088386 ChEBI: 135576 CHEMBL188185 ChemSpider: 2378 PubChem:2472 PubChem:347828509 RxCUI: 19850 Wikipedia: Bunazosin ZINC: ZINC000000601249
Target Activities (3)
DrugBank Target Actions (1)
| Target | Gene | Target Name | Action | Type |
|---|---|---|---|---|
| P25100 | ADRA1D | Alpha-1D adrenergic receptor | modulator | targets |